Author(s): Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R
Background:Multiple Sclerosis is associated with low serum levels of 25-hydroxyvitamin D (25(OH)D). We investigated the association between serum levels of 25(OH)D and 1,25-dihydroxyvitamin D (1,25(OH)2D), the biologically active metabolite, and clinical MS severity as expressed by EDSS-score and relapse rate.
Study-design:Cross-sectional study.
Patients and methods:Serum samples from 267 MS patients were collected for 25(OH)D and 1,25(OH)2D measurement. Clinical MS parameters at the date of serum sampling were determined.
Results:Both metabolite levels were significantly lower in the progressive forms compared to the relapsing remitting (RR)MS phenotype. In RRMS patients (disease course < or = 5 years), high 25(OH)D levels were associated with a high chance of remaining relapse-free. Low 25(OH)D levels were associated with high EDSS-scores. 1,25(OH)2D was not directly associated with relapse rate or EDSS-score, and was dependent of age and 25(OH)D level.
Conclusion:Serum levels of 25(OH)D were associated with both relapse rate and disability in MS patients. These results are suggestive for a disease modulating effect of the serum concentrations of 25(OH)D on MS. The low circulating 1,25(OH)2D levels in progressive MS are due to older age and lower 25(OH)D levels. The potential consequences for vitamin D supplementation in MS will be discussed.
Referred From: https://pubmed.ncbi.nlm.nih.gov/18653736/
Author(s): Sundström P, Nyström M, Ruuth K, Lundgren E
Author(s): Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L
Author(s): Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B
Author(s): Langer-Gould A, Albers KB, Van Den Eeden SK, Nelson LM
Author(s): Muthian G, Raikwar HP, Rajasingh J, Bright JJ
Author(s): Niino M, Miyazaki Y, Fukazawa T, Kikuchi S
Author(s): Ascherio A, Munger K
Author(s): Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, et al.
Author(s): Gourraud PA, Harbo HF, Hauser SL, Baranzini SE
Author(s): Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A
Author(s): Dwyer T, van der Mei I, Ponsonby AL, Taylor BV, Stankovich J, et al.
Author(s): Hayes CE
Author(s): Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F
Author(s): Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S
Author(s): Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, et al.
Author(s): Kazemi A, Sharifi F, Jafari N, Mousavinasab N
Author(s): Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F
Author(s): Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al.
Author(s): Paty DW, Oger JJ, Kastrukoff LF, Hashimoto SA, Hooge JP, et al.
Author(s): Cashman KD, Hill TR, Lucey AJ, Taylor N, Seamans KM, et al.
Author(s): Saka M, Saka M, Koseler E, Metin S, Bilen S, et al.
Author(s): Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R
Author(s): Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, et al.
Author(s): van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, et al.
Author(s): Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelman D, et al.
Author(s): Kampman MT, Wilsgaard T, Mellgren SI
Author(s): van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, et al.
Author(s): Hayes CE, Donald Acheson E
